Zeiss Pharma Limited

Zeiss Pharma Limited - pharma in Panchkula, Haryana, India. FY 2026 financials and compliance.
CIN U24233HR2014PLC052139 Incorporated 13 March 2014 ROC Delhi HQ Panchkula, Haryana, India
Active Public Limited Company pharma
Data last updated
Revenue · FY 2025
₹310.78 Cr
▲ 13.00% YoY
EBITDA · FY 2025
*****
▲ 43.00% YoY
Net profit · FY 2025
*****
▲ 167.00% YoY
Authorised capital
₹15 Cr
Registered with MCA
Paid-up capital
₹14.05 Cr
Issued & subscribed
Open charges
₹190.23 Cr
Secured borrowings
Company age
12 yrs
Est. 2014
Employees · EPFO
155
Latest available

About Zeiss Pharma Limited

Data last updated: 20 December 2025

Zeiss Pharma Limited is a public limited company based in Panchkula, Haryana, India, a subsidiary of Zeiss Pharmaceuticals Private Limited. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 13 March 2014, the company has been in operation for over 12 years.

Registered with ROC Delhi under CIN U24233HR2014PLC052139.

Capital: an authorised share capital of ₹15 Cr and a paid-up capital of ₹14.05 Cr. It is led by directors including Satyapal Bansal and Neeraj Bansal.

Last AGM: 30 September 2024. Financial statements filed for year ended 31 March 2024. Office: 4Th Floor Plot No.16 Sector 22 It Park, Panchkula, Haryana, India – 134109.

As per the financials filed for FY 2025, the company reported a revenue of ₹310.78 Cr, a growth of 13% compared to the previous year.

The company has a workforce of approximately 155 employees as per the latest available data. It operates as a subsidiary of Zeiss Pharmaceuticals Private Limited.

As per MCA filings, the company has open charges of ₹190.23 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website zpharma.co.in.

Company Details of Zeiss Pharma Limited
CIN U24233HR2014PLC052139
Registration Number 052139
Incorporation Date 13 March 2014
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Parent Company Zeiss Pharmaceuticals Private Limited
Compliance Status Active Compliant
Key People
Vikas Gupta Whole-Time Director Vinij Gupta Cfo Satyapal Bansal Director
Contact Details
  • Email
    *****@*****.com
  • Telephone
    +91-****-******
  • Website
    zpharma.co.in
  • Social Media
    **************
  • Registered Address
    4Th Floor Plot No.16 Sector 22 It Park, Panchkula, Haryana, India – 134109
  • Industry
    Pharma, Drug Formulation & Development
Company report
Zeiss Pharma Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Zeiss Pharma Limited report

Financials, compliance, directors, charges, ownership and filings for Zeiss Pharma Limited in one report.

10-year financials Directors & ownership Charges & compliance

Business Activity of Zeiss Pharma Limited

Zeiss Pharma Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products *********

Auditor Details of Zeiss Pharma Limited

Zeiss Pharma Limited is audited by VINEY GOEL & ASSOCIATES for the financial year 2024. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
VINEY GOEL & ASSOCIATES blur-value blur-value blur-value

Board of Directors of Zeiss Pharma Limited

Zeiss Pharma Limited is currently managed by 7 directors, with 3 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Satyapal Bansal
Also directs: Bansal Finefoods Private Limited
Director 25 Apr 2016 10 Years 2 Months Current
Neeraj Bansal
Also directs: Bansal Finefoods Private Limited
Director 25 Apr 2016 10 Years 2 Months Current
Sat Pal
Also directs: Zeiss Pharmaceuticals Private Limited
Director 13 Mar 2014 12 Years 3 Months Current
Vikas Gupta
Also directs: Zeiss Pharmaceuticals Private Limited, Mczeiss Life Science Llp
Whole-Time Director 13 Mar 2014 12 Years 3 Months Current
Vinij Gupta
Also directs: Zeiss Pharmaceuticals Private Limited
Cfo 24 Apr 2016 10 Years 2 Months Current
Showing 6 of 7 current directors. View all directors

Financials of Zeiss Pharma Limited FY 2024 filings available

Zeiss Pharma Limited reported revenue of ₹310.78 Cr (up 13% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue
₹310.78 Cr ▲ 13%
Profit
***** ▲ 167%
EBITDA
***** ▲ 43%
Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****

Consolidated Statements

Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.

Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated - Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF

Shareholding Pattern of Zeiss Pharma Limited

As of FY 2024, Zeiss Pharma Limited's shareholding pattern shows 100.00% by promoters. The promoters hold a majority stake, indicating strong promoter control.

2025
YEAR
38.19% Promoters
25.22% DII (Domestic Institutional)
10.28% FII (Foreign Institutional)
25.89% Public
2.42% Others
Shareholding Trend
Year 2025
Promoters 33.19%
DII 23.22%
FII 18.28%
Public 22.89%
Others 2.42%

Charges & Borrowings of Zeiss Pharma Limited

Open charges
₹190.23 Cr
Satisfied charges
₹0
Breakdown by lending institutions
Hdfc Bank Limited₹190.23 Cr
Latest charge details
DateLenderAmountStatus
21 Aug 2017 Hdfc Bank Limited ₹10 Cr Open
30 Nov 2015 Hdfc Bank Limited ₹180.23 Cr Open

Total charge records: 2 View all charges

Employees and EPFO Compliance at Zeiss Pharma Limited

Zeiss Pharma Limited has a workforce of 155 employees as of Mar 29, 2024.

Employee count
155
Active EPFO establishments
1
Employee growth
14.81%
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Zeiss Pharma Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Zeiss Pharma Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Zeiss Pharma Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Zeiss Pharma Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Zeiss Pharma Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Zeiss Pharma Limited

MSME Payment Delays by Zeiss Pharma Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Zeiss Pharma Limited

Subsidiaries & Group Companies of Zeiss Pharma Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Zeiss Pharma Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Zeiss Pharma Limited

MCA Filings & Documents of Zeiss Pharma Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Zeiss Pharma Limited

Directors
06 Dec 2024
Vikas Gupta was appointed as a Ceo on 06 Dec 2024 & has been associated with this company since 1 year 7 months.
Activity
30 Sep 2024
Zeiss Pharma Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Activity
31 Mar 2024
Zeiss Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Charges
13 Mar 2024
A charge with Hdfc Bank Limited of Rs. 180.23 Cr registered on 30 Nov 2015 with Charge ID 10614311 was modified on 13 Mar 2024.
Directors
23 Jan 2024
Rupam was appointed as a Company Secretary on 23 Jan 2024 & has been associated with this company since 2 years 5 months.
Charges
21 Aug 2017
A charge with Hdfc Bank Limited amounted to Rs. 10.00 Cr with Charge ID 100136360 was registered on 21 Aug 2017.

Frequently Asked Questions about Zeiss Pharma Limited

Zeiss Pharma Limited is an active public limited company in the pharma sector based in Panchkula, Haryana, India. It was incorporated on 13 March 2014 (12+ years old) and is registered under CIN U24233HR2014PLC052139. The company has 155 employees.

Zeiss Pharma Limited reported revenue of ₹310.78 Cr for FY 2025 (up 13.00% YoY).

The current directors of Zeiss Pharma Limited are:

The primary industry of Zeiss Pharma Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Zeiss Pharma Limited can be reached at the registered office: 4Th Floor Plot No.16 Sector 22 It Park, Panchkula, Haryana, India – 134109, or through the website zpharma.co.in.

The authorised capital is ₹15 Cr, and the paid-up capital is ₹14.05 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available